Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.

Abstract

We studied the relative impact of donor source on outcomes following myeloablative hematopoietic stem cell transplantation (HSCT) for adult patients with acute lymphocytic leukemia (ALL). In this single center study, 138 patients aged 18-61 (median 31) years underwent myeloablative conditioning followed by allogeneic HSCT. Stem cell source was an HLA… (More)
DOI: 10.1016/j.bbmt.2008.09.021

Topics

Cite this paper

@article{Kumar2008AllogeneicHS, title={Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.}, author={Priya Kumar and Todd E. Defor and Claudio G Brunstein and Juliet N. Barker and John E Wagner and Daniel J. Weisdorf and L. Burns}, journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation}, year={2008}, volume={14 12}, pages={1394-400} }